Andrew M. Scott
Queen's University Belfast(GB)Target (United States)(US)University of Antwerp(BE)The University of Melbourne(AU)University of Melbourne(AU)Amherst College(US)La Trobe University(AU)Parks Victoria(AU)Austin Hospital(AU)St Vincent's Hospital Sydney(AU)York Teaching Hospital NHS Foundation Trust(GB)Olivia Newton-John Cancer Wellness & Research Centre(AU)Austin Health(AU)Austin Health(AU)St. Joseph’s Healthcare Hamilton(CA)RMIT University(AU)McMaster University(CA)
Publications by Year
Research Areas
Radiopharmaceutical Chemistry and Applications, Medical Imaging Techniques and Applications, Monoclonal and Polyclonal Antibodies Research, HER2/EGFR in Cancer Research, Radiomics and Machine Learning in Medical Imaging
Most-Cited Works
- → Antibody therapy of cancer(2012)2,121 cited
- → Comparison of ultracentrifugation, density gradient separation, and immunoaffinity capture methods for isolating human colon cancer cell line LIM1863-derived exosomes(2012)1,135 cited
- → [177Lu]Lu-PSMA-617 versus cabazitaxel in patients with metastatic castration-resistant prostate cancer (TheraP): a randomised, open-label, phase 2 trial(2021)1,014 cited
- A Phase I dose-escalation study of sibrotuzumab in patients with advanced or metastatic fibroblast activation protein-positive cancer.(2003)
- → Recombinant NY-ESO-1 protein with ISCOMATRIX adjuvant induces broad integrated antibody and CD4+ and CD8+ T cell responses in humans(2004)438 cited
- → Persistence and Efficacy of Second Generation CAR T Cell Against the LeY Antigen in Acute Myeloid Leukemia(2013)429 cited